B
Biosysen
Bioware company, and a species designer
About Biosysen
Biosysen is a synthetic biotechnology company that specializes in species design, utilizing software engineering principles to enhance the productivity of the bioindustry. The company's core offering is a platform for synthetic biology that aids in drug research and development. Their key products include a library of artificial species and what they term "Bioware," which is created through computer-aided genome design.
Read full description
Operating in the biotechnology sector, Biosysen serves clients in the pharmaceutical and food industries, particularly in the area of fermented foods. The company was founded in 2019 and is based in Shenzhen, Guangdong, China. Biosysen has successfully raised capital through two funding rounds, backed by investors such as Sky9 Capital and Linear Venture.
At a glance
- Founded
- 2019
- Headquarters
- Shenzhen, China
- Sector
- Biotech & Life Sciences
Latest news
Press, funding announcements and product moves mentioning Biosysen.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed5 investors entered at this stage
Vitalbridge Capital
Qiji Chuangtan
Linear Capital
Sky9 Capital
HSG
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Biosysen on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Biosysen on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.